Cargando…
Growth Differentiation Factor 15 and Risk of Death in Haemodialysis Patients
AIM: Noninvasive identification of haemodialysis patients at high risk of cardiovascular events and death might improve their outcome. Growth differentiation factor 15 is a prognostic biomarker in multiple disease entities, including cardiovascular disease. The aim of this study was to assess the as...
Autores principales: | Calen, Christelle, Von Moos, Seraina, Cippà, Pietro, Mebazaa, Alexandre, Arrigo, Mattia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063357/ https://www.ncbi.nlm.nih.gov/pubmed/37008733 http://dx.doi.org/10.1155/2023/5163548 |
Ejemplares similares
-
Growth Differentiation Factor 15 Predicts Cancer Death in Patients With Cardiovascular Risk Factors: The J-HOP Study
por: Negishi, Keita, et al.
Publicado: (2021) -
Plasma bio-adrenomedullin is a marker of acute heart failure severity in patients with acute coronary syndrome
por: Arrigo, Mattia, et al.
Publicado: (2019) -
Growth Differentiation Factor‐15 Predicts Death and Stroke Event in Outpatients With Cardiovascular Risk Factors: The J‐HOP Study
por: Negishi, Keita, et al.
Publicado: (2021) -
Aldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patients
por: Drechsler, Christiane, et al.
Publicado: (2013) -
Epicutaneous Immunotherapy for Aeroallergen and Food Allergy
por: Senti, Gabriela, et al.
Publicado: (2013)